Assessment of neuroactive steroid formation in diabetic rat spinal cord using high-performance liquid chromatography and continuous flow scintillation detection

Neurochemistry International

Volumn 52, Issue 4-5, 2008, Pages 554-559

  Mensah Nyagan, Ayikoe Guy ^a   Saredi, Simona ^b   Schaeffer, Veronique ^a   Kibaly, Cherkaouia ^a   Meyer, Laurence ^a   Melcangi, Roberto Cosimo ^b   Patte Mensah, Christine ^a  

^a CNRS   (France)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Diabetes; HPLC; Neuroprotection; Neurosteroid; Pulse chase; Spinal cord; Steroids and the nervous system

Indexed keywords

PROGESTERONE; STEROID; STREPTOZOCIN;

DIABETES MELLITUS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; SCINTILLATION; SENSORIMOTOR FUNCTION; SHORT SURVEY; SPINAL CORD; STEROID METABOLISM; SYNAPTOGENESIS;

ANIMALS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, EXPERIMENTAL; NEUROTRANSMITTER AGENTS; RATS; SCINTILLATION COUNTING; SPINAL CORD; STEROIDS;

RATTUS;

EID: 38549134968     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuint.2007.06.010     Document Type: Short Survey

References (56)

1. Baulieu E.E., Robel P., and Schumacher M. Contemporary Endocrinology (1999), Humana Press, Totowa pp. 1-377
2. Belelli D., and Lambert J.J. Neurosteroids: endogenous regulators of the GABA(A) receptor. Nat. Rev. Neurosci. 6 (2005) 565-575
3. Bitar M.S., and Pilcher C.W. Diabetes attenuates the response of the lumbospinal noradrenergic system to idazoxan. Pharmacol. Biochem. Behav. 67 (2000) 247-255
4. Bukusoglu C., and Krieger N.R. Photoaffinity labeling with progesterone-11 alpha-hemisuccinate- (2-[125I]iodohistamine) identifies four protein bands in mouse brain membranes. J. Neurochem. 63 (1994) 1434-1438
5. Chen S.R., and Pan H.L. Hypersensitivity of spinothalamic tract neurons associated with diabetic neuropathic pain in rats. J. Neurophysiol. 87 (2002) 2726-2733
6. Chen S.R., and Pan H.L. Antinociceptive effect of morphine, but not mu opioid receptor number, is attenuated in the spinal cord of diabetic rats. Anesthesiology 99 (2003) 1409-1414
7. Ciriza I., Azcoitia I., and Garcia-Segura L.M. Reduced progesterone metabolites protect rat hippocampal neurones from kainic acid excitotoxicity in vivo. J. Neuroendocrinol. 16 (2004) 58-63
8. Coirini H., Gouezou M., Liere P., Delespierre B., Pianos A., Eychenne B., Schumacher M., and Guennoun R. 3Beta-hydroxysteroid dehydrogenase expression in rat spinal cord. Neuroscience 113 (2002) 883-891
9. Courteix C., Eschalier A., and Lavarenne J. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53 (1993) 81-88
10. Ghoumari A.M., Ibanez C., El-Etr M., Leclerc P., Eychenne B., O'Malley B.W., Baulieu E.E., and Schumacher M. Progesterone and its metabolites increase myelin basic protein expression in organotypic slice cultures of rat cerebellum. J. Neurochem. 86 (2003) 848-859
11. Gispen W.H., and Biessels G.J. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci. 23 (2000) 542-549
12. Gonzalez Deniselle M.C., Lopez-Costa J.J., Saavedra J.P., Pietranera L., Gonzalez S.L., Garay L., Guennoun R., Schumacher M., and De Nicola A.F. Progesterone neuroprotection in the Wobbler mouse, a genetic model of spinal cord motor neuron disease. Neurobiol. Dis. 11 (2002) 457-468
13. Jacobson A.M., Samson J.A., Weinger K., and Ryan C.M. Diabetes, the brain, and behavior: is there a biological mechanism underlying the association between diabetes and depression?. Int. Rev. Neurobiol. 51 (2002) 455-479
14. Kaneto H., Fujii J., Seo H.G., Suzuki K., Matsuoka T., Nakamura M., Tatsumi H., Yamasaki Y., Kamada T., and Taniguchi N. Apoptotic cell death triggered by nitric oxide in pancreatic beta-cells. Diabetes 44 (1995) 733-738
15. Kapur D. Neuropathic pain and diabetes. Diabetes Metab. Res. Rev. 19 Suppl. 1 (2003) S9-S15
16. Kibaly C., Patte-Mensah C., and Mensah-Nyagan A.G. Molecular and neurochemical evidence for the biosynthesis of dehydroepiandrosterone in the adult rat spinal cord. J. Neurochem. 93 (2005) 1220-1230
17. Koenig H.L., Schumacher M., Ferzaz B., Thi A.N., Ressouches A., Guennoun R., Jung-Testas I., Robel P., Akwa Y., and Baulieu E.E. Progesterone synthesis and myelin formation by Schwann cells. Science 268 (1995) 1500-1503
18. Kuhn-Velten N., Waldenburger D., and Staib W. Evaluation of steroid biosynthetic lesions in isolated Leydig cells from the testes of streptozotocin-diabetic rats. Diabetologia 23 (1982) 529-533
19. Labombarda F., Guennoun R., Gonzalez S., Roig P., Lima A., Schumacher M., and De Nicola A.F. Immunocytochemical evidence for a progesterone receptor in neurons and glial cells of the rat spinal cord. Neurosci. Lett. 288 (2000) 29-32
20. Labombarda F., Gonzalez S.L., Deniselle M.C., Vinson G.P., Schumacher M., De Nicola A.F., and Guennoun R. Effects of injury and progesterone treatment on progesterone receptor and progesterone binding protein 25-Dx expression in the rat spinal cord. J. Neurochem. 87 (2003) 902-913
21. Lambert J.J., Belelli D., Peden D.R., Vardy A.W., and Peters J.A. Neurosteroid modulation of GABAA receptors. Prog. Neurobiol. 71 (2003) 67-80
22. Leonelli E., Bianchi R., Cavaletti G., Caruso D., Crippa D., Garcia-Segura L.M., and Melcangi R.C. Progesterone and its derivatives are neuroprotective agents in experimental diabetic neuropathy: a multimodal analysis. Neuroscience 144 (2007) 1293-1304
23. Majewska M.D. Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance. Prog. Neurobiol. 38 (1992) 379-395
24. Martini L., Magnaghi V., and Melcangi R.C. Actions of progesterone and its 5alpha-reduced metabolites on the major proteins of the myelin of the peripheral nervous system. Steroids 68 (2003) 825-829
25. Melcangi R.C., Magnaghi V., Galbiati M., and Martini L. Formation and effects of neuroactive steroids in the central and peripheral nervous system. Int. Rev. Neurobiol. 46 (2001) 145-176
26. Melcangi R.C., Martini L., and Galbiati M. Growth factors and steroid hormones: a complex interplay in the hypothalamic control of reproductive functions. Prog. Neurobiol. 67 (2002) 421-449
27. Melcangi R.C., Cavarretta I.T., Ballabio M., Leonelli E., Schenone A., Azcoitia I., Miguel Garcia-Segura L., and Magnaghi V. Peripheral nerves: a target for the action of neuroactive steroids. Brain Res. Brain Res. Rev. 48 (2005) 328-338
28. Mensah-Nyagan A.G., Feuilloley M., Dupont E., Do-Rego J.L., Leboulenger F., Pelletier G., and Vaudry H. Immunocytochemical localization and biological activity of 3 beta-hydroxysteroid dehydrogenase in the central nervous system of the frog. J. Neurosci. 14 (1994) 7306-7318
29. Mensah-Nyagan A.G., Do-Rego J.L., Feuilloley M., Marcual A., Lange C., Pelletier G., and Vaudry H. In vivo and in vitro evidence for the biosynthesis of testosterone in the telencephalon of the female frog. J. Neurochem. 67 (1996) 413-422
30. Mensah-Nyagan A.G., Feuilloley M., Do-Rego J.L., Marcual A., Lange C., Tonon M.C., Pelletier G., and Vaudry H. Localization of 17beta-hydroxysteroid dehydrogenase and characterization of testosterone in the brain of the male frog. Proc. Natl. Acad. Sci. U.S.A. 93 (1996) 1423-1428
31. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. Neurosteroids: expression of steroidogenic enzymes and regulation of steroid biosynthesis in the central nervous system. Pharmacol. Rev. 51 (1999) 63-81
32. Mensah-Nyagan A.G., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. Anatomical and biochemical evidence for the synthesis of unconjugated and sulfated neurosteroids in amphibians. Brain Res. Brain Res. Rev. 37 (2001) 13-24
33. Mensah-Nyagan A.G., Do-Rego J.L., Beaujean D., Luu-The V., Pelletier G., and Vaudry H. Regulation of neurosteroid biosynthesis in the frog diencephalon by GABA and endozepines. Horm. Behav. 40 (2001) 218-225
34. Patte-Mensah C., Kappes V., Freund-Mercier M.J., Tsutsui K., and Mensah-Nyagan A.G. Cellular distribution and bioactivity of the key steroidogenic enzyme, cytochrome P450side chain cleavage, in sensory neural pathways. J. Neurochem. 86 (2003) 1233-1246
35. Patte-Mensah C., Li S., and Mensah-Nyagan A.G. Impact of neuropathic pain on the gene expression and activity of cytochrome P450side-chain-cleavage in sensory neural networks. Cell. Mol. Life Sci. 61 (2004) 2274-2284
36. Patte-Mensah C., Penning T.M., and Mensah-Nyagan A.G. Anatomical and cellular localization of neuroactive 5 alpha/3 alpha-reduced steroid-synthesizing enzymes in the spinal cord. J. Comp. Neurol. 477 (2004) 286-299
37. Patte-Mensah C., Kibaly C., and Mensah-Nyagan A.G. Substance P inhibits progesterone conversion to neuroactive metabolites in spinal sensory circuit: a potential component of nociception. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 9044-9049
38. Patte-Mensah C., Kibaly C., Boudard D., Schaeffer V., Begle A., Saredi S., Meyer L., and Mensah-Nyagan A.G. Neurogenic pain and steroid synthesis in the spinal cord. J. Mol. Neurosci. 28 (2006) 17-31
39. Perez Diaz J., Benitez A., and Fernandez Galaz C. Effect of streptozotocin diabetes on the pituitary-testicular axis in the rat. Horm. Metab. Res. 14 (1982) 479-482
40. Ramirez V.D., Zheng J., and Siddique K.M. Membrane receptors for estrogen, progesterone, and testosterone in the rat brain: fantasy or reality. Cell. Mol. Neurobiol. 16 (1996) 175-198
41. Sakamoto H., Ukena K., and Tsutsui K. Effects of progesterone synthesized de novo in the developing Purkinje cell on its dendritic growth and synaptogenesis. J. Neurosci. 21 (2001) 6221-6232
42. Sakamoto H., Ukena K., and Tsutsui K. Dendritic spine formation in response to progesterone synthesized de novo in the developing Purkinje cell in rats. Neurosci. Lett. 322 (2002) 111-115
43. Saredi S., Patte-Mensah C., Melcangi R.C., and Mensah-Nyagan A.G. Effect of streptozotocin-induced diabetes on the gene expression and biological activity of 3beta-hydroxysteroid dehydrogenase in the rat spinal cord. Neuroscience 135 (2005) 869-877
44. Schaeffer V., Patte-Mensah C., Eckert A., and Mensah-Nyagan A.G. Modulation of neurosteroid production in human neuroblastoma cells by Alzheimer's disease key proteins. J. Neurobiol. 66 (2006) 868-881
45. Schumacher M., Guennoun R., Robert F., Carelli C., Gago N., Ghoumari A., Gonzalez Deniselle M.C., Gonzalez S.L., Ibanez C., Labombarda F., Coirini H., Baulieu E.E., and De Nicola A.F. Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination. Growth Horm. IGF Res. 14 Suppl. A (2004) S18-S33
46. Sudha S., Valli G., Julie P.M., Arunakaran J., Govindarajulu P., and Balasubramanian K. Influence of streptozotocin-induced diabetes and insulin treatment on the pituitary-testicular axis during sexual maturation in rats. Exp. Clin. Endocrinol. Diabetes 108 (2000) 14-20
47. Thomas A.J., Nockels R.P., Pan H.Q., Shaffrey C.I., and Chopp M. Progesterone is neuroprotective after acute experimental spinal cord trauma in rats. Spine 24 (1999) 2134-2138
48. Thomas P., Pang Y., Zhu Y., Detweiler C., and Doughty K. Multiple rapid progestin actions and progestin membrane receptor subtypes in fish. Steroids 69 (2004) 567-573
49. Turk J., Corbett J.A., Ramanadham S., Bohrer A., and McDaniel M.L. Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets. Biochem. Biophys. Res. Commun. 197 (1993) 1458-1464
50. Ueshiba H., Shimizu Y., Hiroi N., Yakushiji F., Shimojo M., Tsuboi K., and Miyachi Y. Decreased steroidogenic enzyme 17,20-lyase and increased 17-hydroxylase activities in type 2 diabetes mellitus. Eur. J. Endocrinol. 146 (2002) 375-380
51. Uzunova V., Sheline Y., Davis J.M., Rasmusson A., Uzunov D.P., Costa E., and Guidotti A. Increase in the cerebrospinal fluid content of neurosteroids in patients with unipolar major depression who are receiving fluoxetine or fluvoxamine. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 3239-3244
52. Valera S., Ballivet M., and Bertrand D. Progesterone modulates a neuronal nicotinic acetylcholine receptor. Proc. Natl. Acad. Sci. U.S.A. 89 (1992) 9949-9953
53. Varsik P., Kucera P., Buranova D., and Balaz M. Is the spinal cord lesion rare in diabetes mellitus? Somatosensory evoked potentials and central conduction time in diabetes mellitus. Med. Sci. Monit. 7 (2001) 712-715
54. Yamaguchi Y., Tanaka S., Yamakawa T., Kimura M., Ukawa K., Yamada Y., Ishihara M., and Sekihara H. Reduced serum dehydroepiandrosterone levels in diabetic patients with hyperinsulinaemia. Clin. Endocrinol. (Oxford) 49 (1998) 377-383
55. Yamamoto H., Uchigata Y., and Okamoto H. DNA strand breaks in pancreatic islets by in vivo administration of alloxan or streptozotocin. Biochem. Biophys. Res. Commun. 103 (1981) 1014-1020
56. Zurek J.R., Nadeson R., and Goodchild C.S. Spinal and supraspinal components of opioid antinociception in streptozotocin induced diabetic neuropathy in rats. Pain 90 (2001) 57-63